Tina Q. Tan is a leading figure in infectious diseases, currently serving as the Medical Director of the International Adoptee Clinic at Lurie Children’s Hospital, Chicago.
Tan highlights the importance of vaccinations in preventing serious respiratory diseases, advocating for the immunization against illnesses like influenza, COVID-19, and RSV.
Emerging research emphasizes the long-term impacts of viral infections, driving healthcare professionals to prioritize prevention, particularly through vaccination. Tan asserts that healthcare providers must actively inform patients about the safety and efficacy of vaccines.
The growing challenge of antimicrobial resistance exacerbates the severity of respiratory infections, with studies indicating that unnecessary antibiotic prescriptions are becoming increasingly common. Tan stresses preventive measures, particularly through available vaccines, to mitigate this risk.
Tan connects pediatric respiratory care with global health trends, noting that respiratory infections travel easily across borders. She underscores the significance of vaccination education to combat rising vaccine hesitancy, especially in regions lacking access to comprehensive immunization strategies.
With a focus on international collaboration, Tan advocates for collective efforts to address global respiratory diseases such as tuberculosis, COVID-19, and pertussis. She acknowledges the successes of initiatives to combat vaccine hesitancy among healthcare providers abroad.
Looking towards the future, Tan is optimistic about innovations in respiratory medicine, particularly new vaccine technologies, advanced diagnostics, and surveillance programs. She envisions a landscape where effective vaccines and precision medicine enhance protection against respiratory infections, ultimately shaping pediatric care positively.